Find investors
← Back to all investors
Christopher Steed
ResearchedAngel Investors

Christopher Steed

CIO and Managing Director

Angel InvestorsSeed Round
Pitch Christopher

Get their honest, personalized take on your startup.

Sign in to pitch Christopher

At a glance

Full Name
Christopher Steed
Title
Chief Investment Officer and Managing Director
Firm
Paladin Capital Group
Firm Type
Venture capital; multi-stage, dual-use investor
Investment Stage
Multi-stage; focused on promising early-stage technologies and follow-on support
Target Company Profile
Companies developing technologies for critical cyber, AI, defense, national-security, and advanced-technology needs in both commercial and government markets
Sector Focus
IT security, cybersecurity, AI trust and safety, energy technology, network and communications infrastructure, critical infrastructure protection, mobile technology, alternative energy, distributed sensors/systems/network management, IT services, financial services, data solutions, and life sciences
Geographic Focus
Global, including North America, Australia, Europe, the Middle East, and other worldwide markets
Location
Washington, DC, with Paladin offices in Washington, DC; New York; Silicon Valley; London; and Luxembourg

Background

Christopher Steed is Chief Investment Officer and Managing Director at Paladin Capital Group. He joined Paladin in 2008 and leads development and implementation of the firm’s multi-stage, national-security-related investment strategy, with particular emphasis on Paladin’s global IT and cybersecurity portfolios.

At Paladin, Steed is responsible for deal sourcing, deal execution, and portfolio company management. His firm bio says he has provided board-level oversight for numerous Paladin portfolio companies, including Bugcrowd, CertiVox, Courion, Endgame, Nexidia, PhishMe, and QuantaLife.

Before joining Paladin, Steed worked in Merrill Lynch’s Private Banking and Investment Group, the ultra-high-net-worth division of Merrill’s Private Client Group. He is also a member of the Chartered Alternative Investment Analyst Association and holds the CAIA professional designation, with a specific focus on asset allocation and risk management strategies in private equity and venture capital. I did not find a verified public source for his education history.

Investment Thesis & Focus

  • Paladin describes Steed’s strategy area as “multi-stage, national security-related,” especially global IT and cybersecurity.
  • Paladin’s stated core strength is identifying, supporting, and investing in innovative companies that develop promising early-stage technologies addressing “critical cyber, defense and advanced technology needs” of both commercial and government customers.
  • Cyber Fund II is a $372 million multi-stage fund investing in cybersecurity and online safety sectors, including technologies that protect critical infrastructure and networks from ransomware.
  • Paladin’s AI investing page emphasizes technologies that make AI “trusted and safe,” including AI governance, AI security, watermarking, secure developer training, and video-understanding safety technology.
  • Paladin positions itself as an active investor: before investing, it works with founders and management teams on a specific value-add plan, including board-level help, strategic relationships, government-market navigation, partnerships, recruiting, and follow-on financing.

Notable Investments

  • Bugcrowd - Crowdsourced bug-bounty and security-testing platform; Paladin initial investment date: September 2013.
  • Courion - Identity and access management company; Paladin initial investment date: September 2004.
  • Endgame - Security intelligence and analytics company focused on advanced cyber threats; Paladin initial investment date: March 2013.
  • Nexidia - Audio mining and speech analytics software company; Paladin initial investment date: November 2003.
  • PhishMe - Phishing mitigation and detection platform for enterprise security teams; Paladin initial investment date: July 2012.
  • QuantaLife - Early-stage PCR technology company spun out of Lawrence Livermore National Lab; Paladin initial investment date: June 2008; acquired by Bio-Rad in October 2011.
  • CalypsoAI - AI security platform; Paladin led its $13 million Series A in 2020 and a $23 million follow-on financing in 2023; F5 agreed to acquire the company for $180 million in 2025.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.